Allogene Therapeutics Price Chart
Allogene Therapeutics Volume Chart
Allogene Therapeutics Market Segments
After Hours
+0.03(+1.25%)
| Open | $2.25 |
|---|---|
| Close | $2.28 |
| Low | $2.23 |
| Low Change | -0.02 (-0.89%) |
| High | $2.28 |
| High Change | +0.03 (+1.33%) |
| Range | $0.05 |
| Volume | 10.932K |
| Dollar Volume | $24.91K |
Regular Trading Hours
-0.05(-1.96%)
| Open | $2.30 |
|---|---|
| Close | $2.26 |
| Low | $2.23 |
| Low Change | -0.07 (-3.04%) |
| High | $2.39 |
| High Change | +0.09 (+3.91%) |
| Range | $0.16 |
| Volume | 6.184M |
| Dollar Volume | $13.94M |
Premarket
-0.00(-0.01%)
| Open | $2.29 |
|---|---|
| Close | $2.29 |
| Low | $2.29 |
| Low Change | -0.00 (-0.01%) |
| High | $2.31 |
| High Change | +0.02 (+0.84%) |
| Range | $0.02 |
| Volume | 33.252K |
| Dollar Volume | $76.15K |
After Hours Yesterday
+0.00(+0.00%)
| Open | $2.30 |
|---|---|
| Close | $2.30 |
| Low | $2.28 |
| Low Change | -0.02 (-0.87%) |
| High | $2.30 |
| High Change | +0.00 (+0.00%) |
| Range | $0.02 |
| Volume | 7.552K |
| Dollar Volume | $17.37K |
Regular Trading Hours Yesterday
-0.03(-1.07%)
| Open | $2.33 |
|---|---|
| Close | $2.31 |
| Low | $2.26 |
| Low Change | -0.07 (-3.00%) |
| High | $2.38 |
| High Change | +0.05 (+2.15%) |
| Range | $0.12 |
| Volume | 5.046M |
| Dollar Volume | $11.63M |
Premarket Yesterday
-0.01(-0.43%)
| Open | $2.33 |
|---|---|
| Close | $2.32 |
| Low | $2.31 |
| Low Change | -0.02 (-0.86%) |
| High | $2.36 |
| High Change | +0.03 (+1.29%) |
| Range | $0.05 |
| Volume | 42.043K |
| Dollar Volume | $97.54K |
Allogene Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.35 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.40 |
| 20 Day Moving Average (SMA20) | $2.48 |
| 50 Day Moving Average (SMA50) | $2.39 |
| 100 Day Moving Average (SMA100) | $1.96 |
| 200 Day Moving Average (SMA200) | $1.59 |
Allogene Therapeutics Statistics
| Average Volume (30 Days) | 13.63M |
|---|---|
| P/E Ratio (Current) | -4.20 |
| EPS (Current) | -$0.55 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$149.63M |
| Cash Ratio | 1.59 |
| Current Ratio | 7.93 |
| Quick Ratio | 7.93 |
| Debt to Equity | 0.00 |
| Enterprise Value | $742.90M |
| EV to EBITDA | -3.82 |
| EV to Sales | — |
| Price to Book | 2.72 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.46% |
| Return on Equity | -0.65% |
Allogene Therapeutics Stock Splits
There have been no stock splits for Allogene Therapeutics (ALLO).
Allogene Therapeutics Dividends
There have been no dividends for Allogene Therapeutics (ALLO).